vs
Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and UL Solutions Inc. (ULS). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $789.0M, roughly 1.8× UL Solutions Inc.). UL Solutions Inc. runs the higher net margin — 8.5% vs 3.6%, a 4.9% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (12.2% vs 6.8%). Option Care Health, Inc. produced more free cash flow last quarter ($130.2M vs $86.0M). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.0% CAGR vs 8.5%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
The UL enterprise is a global private safety company headquartered in Northbrook, Illinois, composed of three organizations, UL Research Institutes, UL Standards & Engagement and UL Solutions.
OPCH vs ULS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $789.0M |
| Net Profit | $51.8M | $67.0M |
| Gross Margin | 19.0% | 49.7% |
| Operating Margin | 5.9% | 15.0% |
| Net Margin | 3.6% | 8.5% |
| Revenue YoY | 12.2% | 6.8% |
| Net Profit YoY | -3.8% | -17.3% |
| EPS (diluted) | $0.32 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $789.0M | ||
| Q3 25 | $1.4B | $783.0M | ||
| Q2 25 | $1.4B | $776.0M | ||
| Q1 25 | $1.3B | $705.0M | ||
| Q4 24 | $1.3B | $739.0M | ||
| Q3 24 | $1.3B | $731.0M | ||
| Q2 24 | $1.2B | $730.0M | ||
| Q1 24 | $1.1B | $670.0M |
| Q4 25 | — | $67.0M | ||
| Q3 25 | $51.8M | $100.0M | ||
| Q2 25 | $50.5M | $91.0M | ||
| Q1 25 | $46.7M | $67.0M | ||
| Q4 24 | $60.1M | $81.0M | ||
| Q3 24 | $53.9M | $88.0M | ||
| Q2 24 | $53.0M | $101.0M | ||
| Q1 24 | $44.8M | $56.0M |
| Q4 25 | — | 49.7% | ||
| Q3 25 | 19.0% | 50.3% | ||
| Q2 25 | 19.0% | 49.4% | ||
| Q1 25 | 19.7% | 48.4% | ||
| Q4 24 | 21.3% | 47.4% | ||
| Q3 24 | 20.1% | 49.0% | ||
| Q2 24 | 20.3% | 50.1% | ||
| Q1 24 | 20.8% | 47.6% |
| Q4 25 | — | 15.0% | ||
| Q3 25 | 5.9% | 19.9% | ||
| Q2 25 | 5.8% | 17.9% | ||
| Q1 25 | 5.9% | 15.5% | ||
| Q4 24 | 6.9% | 15.6% | ||
| Q3 24 | 6.7% | 17.8% | ||
| Q2 24 | 6.6% | 17.3% | ||
| Q1 24 | 6.0% | 13.6% |
| Q4 25 | — | 8.5% | ||
| Q3 25 | 3.6% | 12.8% | ||
| Q2 25 | 3.6% | 11.7% | ||
| Q1 25 | 3.5% | 9.5% | ||
| Q4 24 | 4.8% | 11.0% | ||
| Q3 24 | 4.2% | 12.0% | ||
| Q2 24 | 4.3% | 13.8% | ||
| Q1 24 | 3.9% | 8.4% |
| Q4 25 | — | $0.33 | ||
| Q3 25 | $0.32 | $0.49 | ||
| Q2 25 | $0.31 | $0.45 | ||
| Q1 25 | $0.28 | $0.33 | ||
| Q4 24 | $0.36 | $0.40 | ||
| Q3 24 | $0.31 | $0.44 | ||
| Q2 24 | $0.30 | $0.50 | ||
| Q1 24 | $0.26 | $0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $309.8M | $295.0M |
| Total DebtLower is stronger | $1.2B | $491.0M |
| Stockholders' EquityBook value | $1.4B | $1.3B |
| Total Assets | $3.5B | $2.9B |
| Debt / EquityLower = less leverage | 0.86× | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $295.0M | ||
| Q3 25 | $309.8M | $255.0M | ||
| Q2 25 | $198.8M | $272.0M | ||
| Q1 25 | $171.4M | $267.0M | ||
| Q4 24 | $412.6M | $298.0M | ||
| Q3 24 | $483.0M | $327.0M | ||
| Q2 24 | $376.9M | $295.0M | ||
| Q1 24 | $219.5M | $344.0M |
| Q4 25 | — | $491.0M | ||
| Q3 25 | $1.2B | $544.0M | ||
| Q2 25 | $1.1B | $608.0M | ||
| Q1 25 | $1.1B | $653.0M | ||
| Q4 24 | $1.1B | $742.0M | ||
| Q3 24 | $1.1B | $797.0M | ||
| Q2 24 | $1.1B | $810.0M | ||
| Q1 24 | $1.1B | $879.0M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.4B | $970.0M | ||
| Q4 24 | $1.4B | $904.0M | ||
| Q3 24 | $1.4B | $872.0M | ||
| Q2 24 | $1.4B | $769.0M | ||
| Q1 24 | $1.4B | $671.0M |
| Q4 25 | — | $2.9B | ||
| Q3 25 | $3.5B | $2.9B | ||
| Q2 25 | $3.4B | $2.9B | ||
| Q1 25 | $3.3B | $2.9B | ||
| Q4 24 | $3.4B | $2.8B | ||
| Q3 24 | $3.4B | $2.9B | ||
| Q2 24 | $3.3B | $2.7B | ||
| Q1 24 | $3.2B | $2.8B |
| Q4 25 | — | 0.39× | ||
| Q3 25 | 0.86× | 0.46× | ||
| Q2 25 | 0.82× | 0.56× | ||
| Q1 25 | 0.82× | 0.67× | ||
| Q4 24 | 0.79× | 0.82× | ||
| Q3 24 | 0.78× | 0.91× | ||
| Q2 24 | 0.79× | 1.05× | ||
| Q1 24 | 0.74× | 1.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $139.4M | $144.0M |
| Free Cash FlowOCF − Capex | $130.2M | $86.0M |
| FCF MarginFCF / Revenue | 9.1% | 10.9% |
| Capex IntensityCapex / Revenue | 0.6% | 7.4% |
| Cash ConversionOCF / Net Profit | 2.69× | 2.15× |
| TTM Free Cash FlowTrailing 4 quarters | $220.7M | $403.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $144.0M | ||
| Q3 25 | $139.4M | $155.0M | ||
| Q2 25 | $90.3M | $147.0M | ||
| Q1 25 | $-7.2M | $154.0M | ||
| Q4 24 | $36.1M | $130.0M | ||
| Q3 24 | $160.4M | $150.0M | ||
| Q2 24 | $195.7M | $103.0M | ||
| Q1 24 | $-68.8M | $141.0M |
| Q4 25 | — | $86.0M | ||
| Q3 25 | $130.2M | $109.0M | ||
| Q2 25 | $81.2M | $105.0M | ||
| Q1 25 | $-16.6M | $103.0M | ||
| Q4 24 | $25.8M | $72.0M | ||
| Q3 24 | $150.7M | $84.0M | ||
| Q2 24 | $185.9M | $47.0M | ||
| Q1 24 | $-74.6M | $84.0M |
| Q4 25 | — | 10.9% | ||
| Q3 25 | 9.1% | 13.9% | ||
| Q2 25 | 5.7% | 13.5% | ||
| Q1 25 | -1.2% | 14.6% | ||
| Q4 24 | 2.0% | 9.7% | ||
| Q3 24 | 11.8% | 11.5% | ||
| Q2 24 | 15.1% | 6.4% | ||
| Q1 24 | -6.5% | 12.5% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | 0.6% | 5.9% | ||
| Q2 25 | 0.6% | 5.4% | ||
| Q1 25 | 0.7% | 7.2% | ||
| Q4 24 | 0.8% | 7.8% | ||
| Q3 24 | 0.8% | 9.0% | ||
| Q2 24 | 0.8% | 7.7% | ||
| Q1 24 | 0.5% | 8.5% |
| Q4 25 | — | 2.15× | ||
| Q3 25 | 2.69× | 1.55× | ||
| Q2 25 | 1.79× | 1.62× | ||
| Q1 25 | -0.15× | 2.30× | ||
| Q4 24 | 0.60× | 1.60× | ||
| Q3 24 | 2.98× | 1.70× | ||
| Q2 24 | 3.69× | 1.02× | ||
| Q1 24 | -1.54× | 2.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
ULS
| Industrial | $352.0M | 45% |
| Ongoing Certification Services | $259.0M | 33% |
| Software And Advisory | $102.0M | 13% |
| Software | $75.0M | 10% |
